Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More
Amir Aghdaei, insider at Envista
Amir Aghdaei Insider Alerts

Get notified the next time Amir Aghdaei buys or sells Envista stock. Enter your email address below to get our daily insider buying and selling report.

Amir Aghdaei Insider Information

CEO of Envista
Amir Aghdaei has served as our President and Chief Executive Officer and as a director on our Board since May 2019. Prior to that, Mr. Aghdaei served in multiple leadership roles since joining Danaher Corporation in 2008, including as Vice President - Group Executive since 2011 and with responsibility for Danaher’s Dental business since July 2015. Before joining Danaher, Mr. Aghdaei served in a variety of international leadership roles with Hewlett-Packard Company, Agilent Technologies Inc. and Credence Systems Corporation. Mr. Aghdaei brings to Envista an in-depth knowledge of our Dental business and extensive international experience, which is particularly important given our global footprint. Provided by Tagnifi.

What is Amir Aghdaei's net worth?

The estimated net worth of Amir Aghdaei is at least $23.97 million as of April 7th, 2021. Mr. Aghdaei owns 555,643 shares of Envista stock worth more than $23,970,439 as of January 20th. This net worth approximation does not reflect any other investments that Mr. Aghdaei may own. Additionally, Mr. Aghdaei receives an annual salary of $2,870,000.00 as CEO at Envista. Learn More.

How old is Amir Aghdaei?

Mr. Aghdaei is currently 62 years old. There are 7 older executives and no younger executives at Envista. Learn More.

What is Amir Aghdaei's salary?

As the CEO of Envista Holdings Co., Mr. Aghdaei earns $2,870,000.00 per year.

How do I contact Amir Aghdaei?

The corporate mailing address for Mr. Aghdaei and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]

Has Amir Aghdaei been buying or selling shares of Envista?

Amir Aghdaei has not been actively trading shares of Envista during the last quarter. Most recently, Amir Aghdaei sold 50,408 shares of the business's stock in a transaction on Monday, December 27th. The shares were sold at an average price of $46.75, for a transaction totalling $2,356,574.00.

Who are Envista's active insiders?

Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Jeffrey Kappler (SVP), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO).

Are insiders buying or selling shares of Envista?

During the last twelve months, insiders at the sold shares 30 times. They sold a total of 574,993 shares worth more than $25,013,061.55. The most recent insider tranaction occured on December, 27th when CEO Amir Aghdaei sold 50,408 shares worth more than $2,356,574.00. Insiders at Envista own 0.8 % of the company.

Information on this page was last updated on 12/27/2021.

Amir Aghdaei Insider Trading History at Envista

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/27/2021Sell50,408$46.75$2,356,574.00View SEC Filing Icon  
12/22/2021Sell8,434$44.75$377,421.50View SEC Filing Icon  
4/7/2021Sell70,238$44.03$3,092,579.14555,643View SEC Filing Icon  
4/5/2021Sell28,397$41.76$1,185,858.72510,793View SEC Filing Icon  
3/26/2021Sell680$40.75$27,710.00539,870View SEC Filing Icon  
3/22/2021Sell114,148$40.79$4,656,096.92597,232View SEC Filing Icon  
9/20/2019Buy10,000$22.00$220,000.00
See Full Table

Amir Aghdaei Buying and Selling Activity at Envista

This chart shows Amir Aghdaei's buying and selling at Envista by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Envista Company Overview

Envista logo
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.
Read More

Today's Range

Now: $43.14
Low: $43.03
High: $44.94

50 Day Range

MA: $42.82
Low: $38.15
High: $46.74

2 Week Range

Now: $43.14
Low: $33.75
High: $46.88

Volume

807,713 shs

Average Volume

1,316,907 shs

Market Capitalization

$6.96 billion

P/E Ratio

20.74

Dividend Yield

N/A

Beta

1.75
Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More